Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SKIN NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Early research (Phase 1)Study completedNCT00372424
What this trial is testing

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Who this might be right for
Breast Cancer
Pfizer 26
Not applicableActive Not RecruitingNCT05926024
What this trial is testing

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 253
Large-scale testing (Phase 3)Study completedNCT00201942
What this trial is testing

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 336
Not applicableNot Yet RecruitingNCT07280286
What this trial is testing

Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel

Who this might be right for
Myoma;UterusAdhesion; Uterus, Internal
Federico II University 62
Early research (Phase 1)UnknownNCT01946373
What this trial is testing

T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

Who this might be right for
Melanoma
Karolinska University Hospital 20
Early research (Phase 1)Ended earlyNCT01891669
What this trial is testing

PF-06263507 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more
Pfizer 26
Not applicableStudy completedNCT02028169
What this trial is testing

To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic ArthritisWork Productivity
AbbVie 120
Not applicableNot Yet RecruitingNCT07497191
What this trial is testing

AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

Who this might be right for
Breast CancerPerimenopauseOvarian Reserve
Shengjing Hospital 300
Not applicableUnknownNCT02294890
What this trial is testing

Knee Stiffness in Fibrosis Diathesis

Who this might be right for
Knee Replacement ArthroplastyFibrosisDupuytren's Disease
University Hospital Pellenberg 60
Testing effectiveness (Phase 2)Study completedNCT02102490
What this trial is testing

Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 132
Not applicableStudy completedNCT07072013
What this trial is testing

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,937
Not applicableStudy completedNCT01220960
What this trial is testing

Art Therapy Intervention for Breast Cancer Patients

Who this might be right for
Breast Cancer
Dr. Sarkis Meterissian 64
Not applicableStudy completedNCT02760160
What this trial is testing

Dietary Prevention of Photodamage in Skin With Grapes

Who this might be right for
Non-melanoma Skin Cancer
University of Alabama at Birmingham 18
Testing effectiveness (Phase 2)Study completedNCT01356862
What this trial is testing

Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer

Who this might be right for
Breast Cancer
Alliance Pour La Recherche en Cancerologie 91
Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing

Oral Rigosertib for Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64
Testing effectiveness (Phase 2)Study completedNCT00463788
What this trial is testing

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Merck KGaA, Darmstadt, Germany 181
Early research (Phase 1)Study completedNCT00001270
What this trial is testing

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

Who this might be right for
Breast NeoplasmsLymphomaNeoplasm Metastasis+1 more
National Cancer Institute (NCI) 85
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Not applicableAvailableNCT04853602
What this trial is testing

IFx-Hu2.0 Expanded Access Program

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVMerkel Cell Carcinoma+1 more
TuHURA Biosciences, Inc.
Next Page